Enanta Pharmaceuticals, Inc.
Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
Last updated:
Abstract:
The present invention provides compounds of Formula I, ##STR00001## pharmaceutical compositions comprising these compounds and methods of using these compounds to prevent or treat FXR-mediated or TGR5-mediated diseases or conditions.
Status:
Grant
Type:
Utility
Filling date:
19 May 2020
Issue date:
6 Apr 2021